ACBI3 molecule offers new hope for targeting KRAS mutations in cancer
KRAS is the most mutated gene in cancer with mutations occurring in 17%–25% of all cancers, affecting millions of patients ...
Tag: Drug Discovery
Urgent call for long-term investment in antibiotic research
Antibiotic resistance is a global public health threat. Modern health systems rely on antibiotics to prevent and treat infections, and ...
New method accelerates drug discovery from years to months
Researchers from the University of Cincinnati College of Medicine and Cincinnati Children's Hospital have found a new method to increase ...
SciY and Allchemy announce strategic distribution agreement
SciY is proud to announce a strategic distribution agreement with Allchemy, a pioneer in Artificial Intelligence (AI) driven drug discovery, ...
New compound shows promise in Alzheimer’s preclinical models
A multidisciplinary team of scientists led by Kurt Brunden, Ph.D., at the University of Pennsylvania Perelman School of Medicine, and ...
Researchers use XAI to unlock secrets of drug discovery
Artificial intelligence (AI) has exploded in popularity. It powers models that help us drive vehicles, proofread emails and even design ...
AlphaFold accelerates discovery of potential antipsychotic drugs by outperforming traditional methods
In a recent study published in the journal Science Advances, researchers in Sweden conducted virtual screens of over 16 million ...
2024 is shaping up to be “the year of iPSCs"
Axol CEO Summer Review (Jan-Jun 2024). Image Credit: Mongta Studio/Shutterstock.com We’ve seen a real shift in the industry towards in ...
Revolutionary AI model improves early dementia diagnosis
Cambridge scientists have developed an artificially-intelligent tool capable of predicting in four cases out of five whether people with early ...
Insilico Medicine and Fosun Pharma deliver second preclinical candidate for solid tumor treatment
Insilico Medicine("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, has successfully delivered the second preclinical candidate compound (PCC) ...